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Editorial Comment
Is There Any Long-Term Benefit
From Coronary Artery Bypass
Surgery?*
KANU CHATTERJEE, MR . FRCP, FACC
San Frnneiezn . Cnh%s'i,ia
In this issue of the Journal, Wiseman et al . (1) provide other
evidence for the palliative nature of aortocoronary artery
bypass surgery . They observed that patients can sustain
myocardial infarction after bypass graft surgery . and the
immediate and long-term prognosis of these patients is not
different from that of patients who develop myocardial
infarction without having had previous revascularization .
The probability of survival at I and 5 years postinfaretion
was 90 and 70%c, respectively, in patients with previous
bypass graft surgery and 92 and 75% . respectively, in the
control group with infarction . During follow-up, cardiac
events, including reinfarction, unstable angina and the need
for revascularization surgery . were significantly more com-
mon in the postbypass infarction group .
Factors in long-term prognosis of myocardial infarction .
These unfavorable results were observed even though the
estimated extent of the index infarct was smaller in the
postbypass group than in the control group . Infarct size is an
important determinant of early and late prognosis of patients
with myocardial infarction (2). Why, then, did the postby-
pass patients with infarction not have a better prognosis? In
addition to "infarct size." myocardial ischemia, ventricular
arrhythmia and the magnitude of left ventricular dysfunction
exert independent prognostic influences on the long-term
prognosis of postinfarction patients . Although the differ-
ences in the incidence of myocardial ischemia and arrhyth-
mia in the two groups were not assessed, both groups had a
similar predischarge ejection fraction, suggesting that the
magnitude of left ventricular dysfunction is probably a more
important determinant of the long-term prognosis . A history
of previous myocardial infarction was more frequent in the
postbypass patients than in the control group, indicating that
the net Crcrease in left ventricular function is of more
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proenosuc significance than are mechanism, such as recent
or old myocardial infarction or ischemia . which can induce
dy function . Nevertheless, the study by Wiseman et al . ( I)
,ugest, that, once myocardial infarction develops in pa-
tient, with previous coronary artery bypass su ge,y . the
prognosis is
no better
;ban that of a control group of patients
with myocardial infarction . It is relevant, however- to probe
into the potential causes of recurrence of myocardial ische-
mia and its consequences in patients with previous coronary
artery bypass surgery .
Recurrent ischemia after coronary artery bypass surgery
.
The risk of developing myocardial ischemia and its conse-
quences after revascularization surgery is primarily related
to the frequency of both conduitt occlusion and the progres-
sion of the atherosclerotic pros-,s in grafted and nongrafted
native coronary arteries . In the str. zy of Wiseman et al . (1),
4'- of grafts in the postbypass patients were occluded and
an additional 12% were stenotic . Furthermore, when patent
grafts were taken into account, the extent and severity of
c
r, - artery disease were similar in posstbypass andor .
v
control patients . Thus. it is not surprising that the prognosis
of patients in the two g, ups was similar . II
needs to he
emphasized that only seven patients in the bypass group had
an internal mammary artery graft, which provides a much
higher late graft patency rate
. The patients in the bypass
group (lid not receive aspirin or dipyridamole therapy
. which
have the potential to reduce the incidence of vein graft
occlusions (3). It is conceivable that with more frequent use
of the internal mammary artery as the conduit and institution
of rigorous antiplatelet therapy . the graft patency rate, and
hence the late prognosis of these patients . could have been
improved .
It is also relevant to consider whether the postbypass
patients in this study benefited at all from revascularization
surgery . Significant coronary artery disease must have been
present in these patients for a considerable period of time,
and all had severe enough symptoms to require surgical
therapy an average of 5
.5 years before their index infarction
occurred
. These patients already had evidence for more
severe coronary artery disease at the time of surgery . Thus,
revascularization actually improved the prognosis until the
graft occlusion and progression of the atherosclerotic dis-
ease of the native coronary arteries occurred .
Benefits of bypass surgery . That coronary artery bypass
surgery benefits patients with various acute and chronic
ischemic syndromes has been firmly established
. The mech-
anism for the benefit is prevention or amelioration of myo-
cardial ischemia and its consequences
. Relief of angina and
enhanced exercise tolerance along with unproved quality of
life are enjoyed by the majority of patients for several year,
after successful revascularization (4,5). Regional and global




myocardial metabolic and mechanical function tend to im-
prove . Regional myocardial lactate production at rest or
during induced stress can be prevented . Left ventricular wall
motion abnormalities resulting from ischemia are also ex-
pected to decrease (6
.7).
The potential for a longer life
expectancy after revascularization surgery, compared with
that of medical therapy . has also been demonstrated in some
subsets of patients with atherosclerotic obstructive coronary
artery disease . Corona, y artery bypass surgery significantly
improves survival of patients with left main coronary artery
stenosis (8.9) and of patients with triple or double vessel
disease in which one of the two vessels is the proximal
segment of the left anterior descending coronary artery (9) .
Thus, the benefits of coronary artery bypass surgery can
hardly be denied in the appropriate subsets of patients .
Progression of disease after bypass surgery . These bene-
fits, however, are not expected to last forever, as docu-
mented in the study by Wiseman et al. (I) . .Atherosclerosis
progresses in time not only in the grafted and ungrafted
native coronary arteries but also in the conduits used for
revascularization
. The pathologic changes in saphenous vein
bypass grafts include endothelial damage, medial hypertro-
phy, medial necrosis, fibrous thickening of intima, media and




of blood lipids appears to be a major risk
factor and is associated with progressive intimal fibromus-
cular proliferation or atheroma formation, or both
. Rupture
of the atheromatous plaques with superimposed occlusive
thrombosis also occurs, When the occlusive process involv-
ing the native coronary arteries or the conduits reaches a
critical level, recurrence of myocardial ischemia and its
consequences are expected
. Indeed, long-term follow-up of
patients after saphenous vein bypass graft surgery demon-
strates a progressive decrease in benefit front this surgical
procedure with time . Return of angina is observed with
increasing frequency and survival benefits may decline . In
the Veterans Administration Cooperative Study (11), initial
improvement after coronary artery bypass surgery was
followed by an increase in symptoms and a decrease in
exercise tolerance
to levels similar to those of medically
treated patients at 10 years after surgery
. Survival benefit
also tends to diminish by 7 years after revascularizalion
surgery in the "high risk" subgroups of patients (three
vessel disease and depressed left ventricular function), A
possible explanation for the decrease of favorable results
several years after coronary artery bypass surgery is the
return of myocardial ischemia and its consequences resulting
from late graft occlusion and the progression of disease in
the native coronary arteries
. Thus, angina, myocardial in-




farctipn and sudden death all may occur in these patients
when myocardial perfusion is compromised .
Conclusions . Although coronary artery bypass surgery
provides a substantial benefit in certain subsets of patients
with coronary artery disease, one cannot expect prolonged
benefit without efforts to maintain higher graft patency . Use
of the internal mammary artery as a conduit provides a
better chance of maintaining graft patency, thus its use
should take precedence over that of veins whenever feasible .
Aspirin and dipyridamole can decrease the incidence of vein
graft occlusion and the reduction of total and low density
lipoprotein cholesterol with the use of lipid.lowering agents
may retard progression or even cause regression of athero-
sclerosis of the vein grafts as well as the native coronary
arteries . These therapies should always be considered in
postbypass surgery patients to prolong the benefits of revas-
cularization surgery .
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